Is It True That Stem Cell Conditioned Media for Hair Treatment ‘Has No Evidence’? A Frank Reading of the Three-Tier Ladder of Case Reports, Observational Studies, and Comparative Trials — How to Separate the Quantity and Quality of Research, by Dr. Moriwaki2026.08.10
‘Does stem cell conditioned media really work for hair?’ ‘I’ve heard there’s no evidence for it’ — these are common questions at first consultations for hair regenerative medicine. Online, you often see voices saying ‘there are only case reports, no real evidence.’ In reality, what can and cannot be said about the hair regenerative medicine evidence level for stem cell conditioned media hair treatment? This is not an area where clinicians should give vague answers. In this article, Dr. Moriwaki of AVAN TOKYO Ginza organizes how to read the three-tier ladder of research without confusing ‘quantity’ and ‘quality.’
Key Points of This Article
・’No evidence’ and ‘weak evidence’ are different words. The hair regenerative medicine evidence level is evaluated step by step on a ladder: case reports → observational studies → comparative trials (RCTs)
・In the hair application of stem cell conditioned media, case reports and single-arm observational studies dominate, while large-scale randomized controlled trials (RCTs) are still limited
・Before speaking in black-and-white about ‘whether it works,’ you must check the alignment of target patients, dose, observation period, and evaluation indicators
・When choosing a treatment whose evidence is still developing, agreement on expectations, exit design, and record-keeping become as important as the treatment itself
・From the patient’s side, the useful attitude is not ‘is there research?’ but ‘how well does this research apply to my situation?’ — read together with your physician
‘No Evidence’ and ‘Weak Evidence’ Are Different Things
Let’s begin with terminology. In medicine, ‘no evidence’ precisely means ‘the quality and quantity of research conducted so far is not yet sufficient for decision-making.’ It does not mean ‘proven not to work.’
For example, it is a fact that ‘large-scale randomized controlled trials (RCTs) for stem cell conditioned media hair treatment are still limited.’ However, this represents the state of ‘still under verification,’ not ‘refuted.’ Confusing these two easily leads patients to the extreme judgment ‘then is it useless to receive it?’
Medically, the yardstick for evaluating evidence is fairly common. From bottom to top: expert opinion, case reports, case series, observational studies (single-arm/cohort), non-randomized comparative trials, randomized controlled trials, and systematic reviews — this is the ladder. It is practical to check ‘which step is it currently on,’ not simply ‘is there or isn’t there.’
Where on the Ladder Is the Hair Application of Stem Cell Conditioned Media Now?
At present, reports on stem cell conditioned media hair treatment are distributed as follows. Dr. Moriwaki organizes this together with his clinical impression.
Case Reports and Case Series
This layer is the most numerous, appearing as conference presentations and small-scale papers. The content centers on ‘stem cell conditioned media was administered to the scalp in a few AGA patients, and hair diameter and density improved.’ It serves as the first step in showing clinical response, but the weakness is that without a control group, ‘it is hard to separate the effect from the passage of time or from concurrent treatments.’
Single-Arm Observational Studies
Reports of dozens of cases, tracked with unified administration protocols and evaluation indicators, have been increasing recently. Some combine measurements of hair diameter and hair count per unit area by trichoscopy, and are more objective than case reports. However, without a comparison group, this still does not isolate ‘the effect of stem cell conditioned media itself.’
Randomized Controlled Trials (RCTs)
Though the top-tier evidence, large RCTs in the scalp field of stem cell conditioned media are still few. Studies designed with placebo (such as saline) controls, double-blinding, and 6- to 12-month follow-up are globally limited. This is a future task, and something that should be honestly conveyed to patients.
Reading the Hair Regenerative Medicine Evidence Level by ‘Quantity’ and ‘Quality’
‘There are many papers’ and ‘the evidence for that treatment is strong’ are not the same. One well-designed RCT weighs more as decision material than 100 case reports — this is the basic thinking of clinical research.
Conversely, dismissing ‘no RCT yet = meaningless’ is also not practical. Many treatments long used in orthopedics and dermatology first began as accumulations of case reports and observational studies, and grew into higher-tier evidence over time. For AGA treatment guidelines, it is practical to refer to publications such as the Japanese Dermatological Association.
What matters is to share with your physician ‘which step this treatment is currently on,’ and then read ‘within that step, how well does the report apply to your situation.’ Other explanatory articles from our clinic can be followed from this list of related hair regenerative medicine columns.
Five Questions Patients Can Use to Make Decisions
To read the hair regenerative medicine evidence level as ‘your own concern,’ it is useful to ask your physician these five questions.
1. Are the patients in the report close to you?
Age, sex, AGA progression, medical history, concurrent treatments. The closer these are to yours, the more the study’s conclusions apply to you.
2. Are dose, site, and frequency aligned with the clinic’s treatment design?
If the preparation, dose, and injection layer used in the paper differ from the treatment conditions you will actually receive, the conclusions do not apply as-is.
3. Are the evaluation indicators subjective or objective?
Not only ‘the patient’s own satisfaction’ but also photographs, trichoscopy, and hair diameter measurements — objective indicators lend credibility.
4. Is the observation period sufficient?
Given the hair cycle, at least 3 to 6 months is desirable for observing initial changes, and 12 months or more for evaluating maintenance.
5. Are conflicts of interest (COI) disclosed?
Whether the manufacturer or medical institution provided funding affects the interpretation of research. The disclosure section is worth checking.
Is ‘Waiting Until the Evidence Is Complete’ the Right Answer?
‘I’ll wait until RCTs are complete’ is one valid choice. However, AGA is a progressive disease, and hair follicle miniaturization advances while you wait. Balancing the cost of waiting for perfect evidence against the cost of intervening early based on interim evidence — deciding based on each patient’s progression speed and values — this is where real clinical practice lands.
For this reason, at AVAN TOKYO Ginza, at the first consultation we always clarify three points: ‘at what step of evidence does stem cell conditioned media hair treatment currently stand,’ ‘why are we proposing it to you,’ and ‘what are the criteria for stopping or changing if the effect is poor.’ Effects vary individually, and we do not guarantee satisfying changes for every patient.
Frequently Asked Questions
Q. I was told stem cell conditioned media hair treatment ‘has no evidence’ and I shouldn’t receive it. Is that true?
‘No evidence’ is not synonymous with ‘doesn’t work.’ At present, case reports and observational studies dominate, and large RCTs are still limited. Whether to receive it is a matter to decide together with your AGA progression, response to other treatments, expectations, and cost tolerance — it is neither ‘uniformly meaningless’ nor ‘uniformly must-receive.’
Q. Is a treatment with more papers more reassuring?
Quantity and quality are different axes. One well-designed RCT carries more weight as decision material than 100 case reports. Beyond numbers, check for controls, blinding, observation period, and evaluation indicators.
Q. How does Dr. Moriwaki explain the hair regenerative medicine evidence level?
Of the ladder ‘case reports → single-arm observation → comparative trial → RCT → systematic review,’ the scalp application of stem cell conditioned media currently has most reports clustering around single-arm observational studies to non-randomized comparative trials. He explains this as being ‘in progress,’ not ‘refuted.’
Q. When receiving a treatment with weak evidence, what should the patient watch out for?
Three things: pre-agreement on expectations, standardized recording with photographs and trichoscopy, and pre-agreement on effect judgment and stopping criteria. Precisely because evidence is developing, having a personal mechanism to judge effects leads to decisions you will not regret.
Q. Is stem cell conditioned media hair treatment listed as a recommendation in the Japanese Dermatological Association guidelines?
The Japanese Dermatological Association’s guidelines for androgenetic alopecia are structured mainly around the recommendation grades of oral and topical medications, and there is no current entry recommending stem cell conditioned media in parallel with an ‘A grade’ rating. This fact should be honestly conveyed at the first consultation; concealing or over-reinforcing it is not sincere.
──────────────
[Supervisor] Shin Moriwaki, M.D. (Supervising Physician)
Member of the Japan Society of Aesthetic Surgery (JSAS) / Member of the American Academy of Aesthetic Medicine
ECFMG Certificate
──────────────
📍AVAN TOKYO 銀座 毛髪再生医療
AVAN TOKYO Ginza Hair Regenerative Medicine
English / 中文 / Tiếng Việt available
For inquiries, please contact us via DM / LINE / Website / Phone.